Hana Pharm. Co., Ltd.
Financials
Valuation Metrics
Hana Pharm. Co., Ltd.'s Market Cap is ₩1578B. At end of 2025 it was ₩1994B. Ranked #952 of 2,436 in KR market (top 39%), #496 of 787 on KOSPI (top 63%), #109 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 47%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 157.82B KRW | KR#952/2,436 Sec#109/234 |
| Revenue | 244.29B KRW | KR#917/2,436 Sec#48/234 |
| Net Income | 14.54B KRW | KR#761/2,436 Sec#50/234 |
| Total Assets | 439.19B KRW | KR#810/2,436 Sec#50/234 |
| Net Assets | 319.51B KRW | KR#675/2,436 Sec#43/234 |
| Employees | 730 | KR#345/2,436 Sec#29/234 |
| Value | ||
| P/E | 10.85x | KR#757/2,436 Sec#40/234 |
| P/B | 0.49x | KR#792/2,436 Sec#32/234 |
| PEG | 0.08x | KR#353/2,436 Sec#19/234 |
| P/S | 0.65x | KR#1,100/2,436 Sec#51/234 |
| EV/EBITDA | 8.03x | KR#463/2,436 Sec#17/234 |
| FCF Yield | 4.73% | KR#884/2,436 Sec#46/234 |
| Profitability | ||
| ROE | 4.55% | KR#1,052/2,436 Sec#77/234 |
| ROA | 3.31% | KR#908/2,436 Sec#79/234 |
| Op. Margin | 11.17% | KR#427/2,436 Sec#38/234 |
| Revenue Growth | 8.32% | KR#998/2,436 Sec#91/234 |
| Earnings Growth | 135.92% | KR#339/2,436 Sec#22/234 |
| Financial Health | ||
| Debt Ratio | 37.46% | KR#130/2,436 Sec#15/234 |
| Total Debt | 63.80B KRW | KR#884/2,436 Sec#62/234 |
| FCF | 7.47B KRW | KR#794/2,436 Sec#49/234 |
| Cash | 2.34B KRW | KR#2,215/2,436 Sec#210/234 |
| Current Ratio | 1.40x | KR#1,391/2,436 Sec#148/234 |
| Net Debt/EBITDA | 2.25x | KR#912/2,436 Sec#67/234 |
| Dividend | ||
| Div. Yield | 3.00% | KR#651/2,436 Sec#31/234 |
| Div. Growth | -49.02% | KR—/2,436 Sec—/234 |
| Performance | ||
| 1Y Return | -24.75% | KR#1,434/2,436 Sec#124/234 |
| 1M Return | 2.42% | KR#651/2,436 Sec#58/234 |
| From 52W High | -28.33% | KR#357/2,436 Sec#22/234 |
| 1Y MDD | -33.63% | KR#306/2,436 Sec#20/234 |
| Trading | ||
| Volume | 34,043 shares | KR#1,572/2,436 Sec#154/234 |
| Foreign Own. | 0.00% | KR—/2,436 Sec—/234 |
| Per Share | ||
| EPS | 818 KRW | KR#714/2,436 Sec#50/234 |
| BPS | 18,028 KRW | KR#562/2,436 Sec#38/234 |
Company Info
Established as Woocheon Pharmaceutical in 1973, this company changed its name to Hana Pharmaceutical in 1996 and was listed in 2018. It leads the market with strengths in narcotic analgesics and anesthetics, conducting specialty pharmaceutical businesses with over 380 health insurance-listed medicines. The company operates a manufacturing plant in Hwaseong, Gyeonggi-do, and an R&D center in Pangyo. It is expanding production through new injectable plant certification and focusing on developing biosimilars and DDS-based improved new drugs. Hana Pharmaceutical was founded in 1978 and is headquartered in Hwaseong-si, Gyeonggi-do.